- Puma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial Results
- Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer
- Puma Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results
- Puma Biotechnology to Participate in a Panel Discussion at TD Cowen’s 44th Annual Health Care Conference
- Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results
- Puma Biotechnology Announces Initiation of ALISCA-Lung1 Phase II Trial of Alisertib in Small Cell Lung Cancer
More ▼
Key statistics
On Friday, Puma Biotechnology Inc (PBYI:NSQ) closed at 5.01, -35.19% below its 52-week high of 7.73, set on Feb 15, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.92 |
---|---|
High | 5.08 |
Low | 4.90 |
Bid | 5.05 |
Offer | 5.20 |
Previous close | 4.99 |
Average volume | 299.38k |
---|---|
Shares outstanding | 48.21m |
Free float | 40.92m |
P/E (TTM) | 11.10 |
Market cap | 241.52m USD |
EPS (TTM) | 0.4515 USD |
Data delayed at least 15 minutes, as of Apr 19 2024 21:00 BST.
More ▼